Welcome to the home for real-time coverage of markets brought to you by Reuters reporters. You can share your thoughts with us at markets.research@thomsonreuters.com
EUROPEAN STOCK FUTURES HEAD SOUTH
European equity markets look set to open the final day of a choppy week in the red, as investors attempt to digest what Trump and his policies might mean for global stocks.
Euro STOXX 50 futures STXEc1 are down around 0.7%, with the index so far having gained about 0.6% for the week. Futures on Germany's DAX .GDAXI, Britain's FTSE .FTSE and France's CAC 40 are down between 0.4%-0.6%.
Trump, late on Thursday, announced Robert F. Kennedy Jr., who has previously spread misinformation on vaccines, to lead the Department of Health and Human Services in his new administration.
European vaccine makers - such as GSK GSK.L, Biontech 22UAy.DE and Sanofi SASY.PA - could be in focus at the open.
In other corporate news, Italy's top insurer Generali GASI.MI posted 9-month profit above estimates, despite a 930 million hit from natural disasters.
On the M&A front, German drug developer Evotec EVTG.DE has received an 11 euros per share offer from Halozyme Therapeutics HALO.O, valuing the company at about 2 billion euros.
(Samuel Indyk)
*****
FRIDAY'S OTHER LIVE MARKETS POSTS:
CHINESE CONSUMERS SPEND MORE, JUST NOT ON PROPERTY CLICK HERE
China's mixed October data keeps stimulus calls alive https://reut.rs/3YPXD6v
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。